Mark Nedelman
Chief Executive Officer at Biomedical Research Models, Inc.
Mark Nedelman active positions
| Companies | Position | Start | End |
|---|---|---|---|
Biomedical Research Models, Inc.
 Biomedical Research Models, Inc. BiotechnologyHealth Technology Biomedical Research Models, Inc. develops and utilizes specialty animal models to determine the efficacy of new drugs in preventing or ameliorating human diseases. It offers contract research, proprietary models,colony management, and partnership services. The company was founded by Dennis L. Guberski in 1996 and is headquartered in Worcester, MA. | Chief Executive Officer | - | - |
Career history of Mark Nedelman
Former positions of Mark Nedelman
| Companies | Position | Start | End |
|---|---|---|---|
Charles River Laboratories, Inc.
 Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA. | Chief Tech/Sci/R&D Officer | - | - |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Chief Tech/Sci/R&D Officer | - | - |
SelectX Pharmaceuticals, Inc.
 SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SelectX Pharmaceuticals, Inc. engages in the discovery and development of aminoglycoside therapeutics for unmet medical needs. Its advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections (HAIs); SXP2523 possesses broad spectrum coverage with potency against Pseudomonas, Klebsiella, Acinetobacter, E. coli, and Staphylococcus. The company was founded by Michael G. Chaparian and Charles R. Cantor in 2002 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Statistics
International
| United States | 5 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
SelectX Pharmaceuticals, Inc.
SelectX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SelectX Pharmaceuticals, Inc. engages in the discovery and development of aminoglycoside therapeutics for unmet medical needs. Its advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections (HAIs); SXP2523 possesses broad spectrum coverage with potency against Pseudomonas, Klebsiella, Acinetobacter, E. coli, and Staphylococcus. The company was founded by Michael G. Chaparian and Charles R. Cantor in 2002 and is headquartered in Boston, MA. | Health Technology |
Charles River Laboratories, Inc.
Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company was founded in 1947 and is headquartered in Wilmington, MA. | Commercial Services |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Biomedical Research Models, Inc.
Biomedical Research Models, Inc. BiotechnologyHealth Technology Biomedical Research Models, Inc. develops and utilizes specialty animal models to determine the efficacy of new drugs in preventing or ameliorating human diseases. It offers contract research, proprietary models,colony management, and partnership services. The company was founded by Dennis L. Guberski in 1996 and is headquartered in Worcester, MA. | Health Technology |
- Stock Market
- Insiders
- Mark Nedelman
- Experience
